• Title/Summary/Keyword: Double primary

Search Result 468, Processing Time 0.025 seconds

Efficacy and Safety of Cheong-A-Won Gagambang (JCE003) on Knee Osteoarthritis: Randomized Controlled Pilot Trial

  • Kong, Haejin;Kang, Jaehui;Lee, Hyun
    • Journal of Acupuncture Research
    • /
    • v.39 no.3
    • /
    • pp.202-212
    • /
    • 2022
  • Background: The aim of this study was to evaluate the effectiveness and safety of Cheong-A-Won Gagambang (JCE003) treatment for degenerative knee osteoarthritis. Methods: This was a single-center, randomized, double-blind, placebo-controlled pilot clinical trial. There were 36 adults with degenerative knee osteoarthritis who were randomly allocated into JCE003 1,000 mg, JCE003 2,000 mg, or the placebo group (in a 1:1:1 ratio). The participants received 12 weeks of treatment and had scheduled tests every 6 weeks. The primary outcomes were measured using the Korean Western Ontario and McMaster Universities scale, and the secondary outcomes were measured using the visual analog scale, European quality of life-5-dimensions, patient global impression of change, C-reactive protein, and erythrocyte sedimentation rate. Changes between baseline scores and scores following study completion were analyzed. Results: There were 29 participants whose data were analyzed in this study. The change of Korean Western Ontario and McMaster Universities, visual analog scale, European quality of life-5-dimensions scores showed significant improvement in the JCE003 1,000 mg group. The change of patient global impression of change was significantly improved in the placebo group. There were 14 adverse events, but there was no clinically significant relationship with the intake of JCE003 compared with the placebo. Conclusion: Taking JCE003 may be effective at improving knee pain in patients with degenerative knee osteoarthritis and appears to be safe. Based on this study, the concentration and feasibility of the test group may be used when conducting a large-scale clinical trial of degenerative knee osteoarthritis in the future.

Can platelet-rich plasma injections provide better pain relief and functional outcomes in persons with common shoulder diseases: a meta-analysis of randomized controlled trials

  • Barman, Apurba;Mishra, Archana;Maiti, Rituparna;Sahoo, Jagannatha;Thakur, Kaustav Basu;Sasidharan, Sreeja Kamala
    • Clinics in Shoulder and Elbow
    • /
    • v.25 no.1
    • /
    • pp.73-89
    • /
    • 2022
  • Background: To evaluate the efficacy of autologous platelet-rich plasma (PRP) injections in the treatment of common shoulder diseases. Methods: The PubMed, Medline, and Central databases and trial registries were searched from their inception to October 2020 for randomized controlled trials of autologous PRP injections for shoulder diseases versus placebo or any control intervention. Preferred reporting items for systematic reviews and meta-analyses (PRISMA) guidelines were followed in the selection, analysis, and reporting of findings. The primary outcome was pain intensity (visual analog scale), and secondary outcomes were changes in function and quality of life (QoL). Results: A total of 17 randomized controlled trials of PRP versus control were analyzed. From 8-12 weeks to ≥1 year, PRP injections were associated with better pain relief and functional outcomes than control interventions. PRP injections were also associated with greater QoL, with an effect size of 2.61 (95% confidence interval, 2.01-14.17) at medium-term follow-up. Compared with placebo and corticosteroid injections, PRP injections provided better pain relief and functional improvement. In subgroup analyses, trials in which PRP was prepared by the double centrifugation technique, the platelet concentration in the PRP was enriched ≥5 times, leucocyte-rich PRP was used, or an activating agent was used before application reported the most effective pain relief at 6-7 months. Conclusions: PRP injections could provide better pain relief and functional outcomes than other treatments for persons presenting with common shoulder diseases. PRP injections have a greater capacity to improve shoulder-related QoL than other interventions.

Evaluation of the efficacy and safety of epidural steroid injection using a nonparticulate steroid, dexamethasone or betamethasone: a double-blind, randomized, crossover, clinical trial

  • Lee, Guen Young;Lee, Joon Woo;Lee, Eugene;Yeom, Jin S.;Kim, Ki-Jeong;Shin, Hyung-Ik;Kang, Heung Sik
    • The Korean Journal of Pain
    • /
    • v.35 no.3
    • /
    • pp.336-344
    • /
    • 2022
  • Background: The U.S. Food and Drug Administration has prohibited epidural steroid injection (ESI) with particulate steroids. Thus, this study aimed to compare the efficacy and safety of ESI with two nonparticulate steroids, dexamethasone and betamethasone. Methods: The eligible patients (n = 600) who received ESI (0 week) with dexamethasone (ESI-dexa) or betamethasone (ESI-beta) had follow-up visits at 2, 4, and 8 weeks with a phone interview at 12 weeks. The primary endpoint was the proportion of effective responders without pain or who were much improved at 2 weeks. The secondary endpoints were the proportion of crossover injections at 2 weeks; changes in the visual analog scale (VAS) and disability index scores at 2, 4, and 8 weeks; the number of additional ESIs in 12 weeks; the number of participants having spinal surgery, as well as the incidence of adverse events over the 12 weeks. Results: The proportion of effective responders at 2 weeks was not different between ESI-beta (72/216, 33.3%) and ESI-dexa (63/200, 31.5%; P = 0.670). Adverse events were more common with ESI-dexa (40/200, 20.0%) than with ESI-beta (24/216, 11.1%; P = 0.012). VAS scores decreased more with ESI-beta than with ESI-dexa at 2 weeks (difference, 0.35; P = 0.023) and 4 weeks (difference, 0.42; P = 0.011). The disability score improved significantly more with ESI-beta compared with ESI-dexa at 2 weeks (difference, 3.37; P = 0.009), 4 weeks (difference, 4.01; P = 0.002), and 8 weeks (difference, 3.54; P = 0.007). Conclusions: Betamethasone would be more appropriate for ESI.

Investigating the performance of polymer cement resistance in football stadium construction

  • Yangguang Zhang
    • Advances in concrete construction
    • /
    • v.15 no.3
    • /
    • pp.203-213
    • /
    • 2023
  • New techniques, technologies, and materials should be used to design and build sports stadiums. Since this century, much progress has been made in covering the roofs of sports stadiums, and the possibility of accurate computer calculation has been provided for stadiums, so by choosing a new structure, we can double the beauty and resistance of these stadiums. A stadium has an excellent and valuable design when its structure, shell, building, materials, and joinery follow a high architectural idea at all levels and scales. This article examines the mechanical performance of polymer cement strength in the construction of football stadiums, along with their structural knowledge in the form of the best examples in the world. Portland cement is one of the most used materials for constructing football stadiums. However, its production requires spending a lot of money, wasting energy, and damaging the environment. Considering the disadvantages in the production and consumption of concrete in different environments, it is necessary to find alternative materials. It should be used with cheaper, simpler technology, abundant primary resources, energy saving, less environmental damage, and better chemical and physical properties in concrete. High-strength concrete technology is considered a new development in the construction industry of concrete structures. In hardened concrete, strength and durability are two main factors, and as the compressive strength of concrete increases, concrete becomes more brittle. As a result, its tensile strength does not increase in proportion to the increase in compressive strength and has less strain tolerance. For this reason, the need to use is evident from the fibers in high-strength concrete. Fibers are used in concrete to increase tensile strength, prevent crack propagation, and significantly increase softness. The increase with the change of these resistances depends on the strength of concrete without fibers, the shape of fibers, and the percentage of fibers. This cement is obtained from the wastes of chemical and petrochemical industries and the wastes from coal combustion, which have the properties mentioned as substitutes for Portland cement.

Observational Feature of Ejecta-Companion Interaction of A Type Ia SN 2021hpr Via The Very Early Light Curve

  • Lim, Gu;Im, Myungshin;Paek, Gregory S.H;Yoon, Sung-Chul;Choi, Changsu;Kim, Sophia;Seo, Jinguk;Kang, Wonseok;Kim, Taewoo;Sung, Hyun-Il;Kim, Yonggi;Yoon, Joh-Na
    • The Bulletin of The Korean Astronomical Society
    • /
    • v.46 no.2
    • /
    • pp.50.3-51
    • /
    • 2021
  • The progenitor of Type Ia supernovae is largely expected as a close binary system of a carbon/oxygen white dwarf (WD) primary and its secondary non-degenerate (single degenerate; SD) or degenerate companion (double degenerate; DD). Here we present a high-cadence monitoring observation of SN 2021hpr in a spiral galaxy, NGC 3147. SN 2021hpr shows typical characteristics as a normal type Ia supernova from its photometric (Δm15(B)=1.01±0.03, dust free MB,max=-19.45±0.02) and spectroscopic data. To investigate its progenitor system, we fit the early part of BVRI-band light curve simultaneously with a combined version of ejecta-companion and simple power-law model. As a result, we found a significant feature of an early excess possibly from a 7.63±0.52R-sized companion at the optimal viewing angle while the fit is not successful at the common viewing angle. No possible red sources brighter than F555W=-7.01 AB mag is detected at the SN location in Hubble Space Telescope (HST) pre-explosion images, excluding massive stars with initial mass of >16M as companions. We suggest the progenitor system of SN 2021hpr can be a fairly large companion such as a main sequence, a low mass subgiant, and a helium giant star. In addition, a possibility of the ejecta-Disk Originated Matter (DOM) interaction for the DD scenario considering linearly-rising early flux still remains.

  • PDF

A Pilot Clinical Study of the Efficacy and Safety of Phellinus Linteus (Sanghuang) Extract Treatment for Knee Osteoarthritis

  • Ryu, Hwa yeon;Lee, Hyun;Kang, Jae Hui
    • Journal of Acupuncture Research
    • /
    • v.39 no.2
    • /
    • pp.115-121
    • /
    • 2022
  • Background: To evaluate the efficacy and safety of Phellinus linteus (PL) extract for the treatment of knee osteoarthritis (KOA) a pilot clinical study was performed. Methods: There were 24 patients with KOA who enrolled in this double-blind, randomized, controlled, clinical trial. There were 3 groups: PL 1,000 mg/day (PL 1,000), PL 1,500 mg/day (PL 1,500), and dextrin 3,000 mg/day (placebo). Patients took capsules twice a day, 3 capsules at a time, over 8 weeks. Patients were monitored prior to treatment (Visit 1: Week 0), and followed up every 4 weeks (Visit 2: Week 4 and Visit 3: Week 8) where outcome measurements were taken. The primary outcome measure was the score from the Korean version of the Western Ontario and McMasters Universities from baseline to Week 8. The secondary outcomes were measurements from the visual analog scale, quality of life scale, erythrocyte sedimentation, and c-reactive protein. Adverse events were recorded at every visit. Results: The Korean version of the Western Ontario and McMasters Universities score showed the greatest improvement in symptoms of KOA in the PL 1,500 group compared with the placebo group. The erythrocyte sedimentation tended to decrease in the PL 1,500 group compared with the placebo group (which was within the normal range). The visual analog scale score decreased in all groups, with no significant differences between groups. No adverse events related to PL were reported. There were no abnormal hematological or physical findings. Conclusion: This pilot clinical trial was the first step to assess the efficacy and safety of PL used in the treatment of patients with KOA.

Alkali Recovery by Electrodialysis Process: A Review (전기투석 공정에 의한 알칼리 회수: 총설)

  • Sarsenbek Assel;Rajkumar Patel
    • Membrane Journal
    • /
    • v.33 no.3
    • /
    • pp.87-93
    • /
    • 2023
  • Electrodialysis (ED) is essential in separating ions through an ion exchange membrane. The disposal of brine generated from seawater desalination is a primary environmental concern, and its recycling through membrane separation technology is highly efficient. Alkali is produced by several chemical industries such as leather, electroplating, dyeing, and smelting, etc. A high concentration of alkali in the waste needs treatment before releasing into the environment as it is highly corrosive and has a chemical oxygen demand (COD) value. The concentration of calcium and magnesium is almost double in brine and is the perfect candidate for carbon dioxide adsorption, a major environmental pollutant. Sodium hydroxide is essential for the metal carbonation process which, is easily produced by the bipolar membrane electrodialysis process. Various strategies are available for its recovery, like reverse osmosis (RO), nanofiltration (NF), ultrafiltration (UF), and ED. This review discusses the ED process by ion exchange membrane for alkali recovery are discussed.

Configurable Smart Contracts Automation for EVM based Blockchains

  • ZAIN UL ABEDIN;Muhammad Shujat Ali;Ashraf Ali;Sana Ejaz
    • International Journal of Computer Science & Network Security
    • /
    • v.23 no.10
    • /
    • pp.147-156
    • /
    • 2023
  • Electronic voting machines (EVMs) are replacing research ballots due to the errors involved in the manual counting process and the lengthy time required to count the votes. Even though these digital recording electronic systems are advancements, they are vulnerable to tampering and electoral fraud. The suspected vulnerabilities in EVMs are the possibility of tampering with the EVM's memory chip or replacing it with a fake one, their simplicity, which allows them to be tampered with without requiring much skill, and the possibility of double voting. The vote data is shared among all network devices, and peer-to-peer verification is performed to ensure the vote data's authenticity. To successfully tamper with the system, all of the data stored in the nodes must be changed. This improves the proposed system's efficiency and dependability. Elections and voting are fundamental components of a democratic system. Various attempts have been made to make modern elections more flexible by utilizing digital technologies. The fundamental characteristics of free and fair elections are intractability, immutability, transparency, and the privacy of the actors involved. This corresponds to a few of the many characteristics of blockchain-like decentralized ownership, such as chain immutability, anonymity, and distributed ledger. This working research attempts to conduct a comparative analysis of various blockchain technologies in development and propose a 'Blockchain-based Electronic Voting System' solution by weighing these technologies based on the need for the proposed solution. The primary goal of this research is to present a robust blockchain-based election mechanism that is not only reliable but also adaptable to current needs.

Effect of Tablet-based Cognitive Intervention on Cognition in Patients With Mild Cognitive Impairment: A Pilot Study

  • Ji Young Park;Seon Ae Choi;Jae Joon Kim;Yu Jeong Park;Chi Kyung Kim;Geum Joon Cho;Seong-Beom Koh;Sung Hoon Kang
    • Dementia and Neurocognitive Disorders
    • /
    • v.22 no.4
    • /
    • pp.130-138
    • /
    • 2023
  • Background and Purpose: Growing evidence has shown that cognitive interventions can mitigate cognitive decline in patients with mild cognitive impairment (MCI). However, most previous cognitive interventions have been group-based programs. Due to their intrinsic limitations, group-based programs are not widely used in clinical practice. Therefore, we have developed a tablet-based cognitive intervention program. This preliminary study investigated the feasibility and effects of a 12-week structured tablet-based program on cognitive function in patients with MCI. Methods: We performed a single-arm study on 24 patients with MCI. The participants underwent a tablet-based cognitive intervention program 5 times a week over a 12-week period. The primary outcome was changes in cognitive function, measured using the Korean version of the Consortium to Establish a Registry for Alzheimer's Disease Assessment Packet (CERAD-K). Outcomes were evaluated at baseline, within two weeks of the last program (post-intervention), and at the six-month follow-up session. Results: The completion rate of the tablet-based program was 83.3% in patients with MCI. The program improved cognitive function based on the CERAD-K total score (p=0.026), which was maintained for at least three months (p=0.004). There was also an improvement in the depression scale score (p=0.002), which persisted for three months (p=0.027). Conclusions: Our 12-week structured tablet-based program is feasible for patients with MCI. Furthermore, although further studies with a double-arm design are required, the program appears to be an effective strategy to prevent cognitive decline in patients with MCI.

Outcomes of endoscopic retrograde cholangiography and percutaneous transhepatic biliary drainage in liver transplant recipients with a Roux-en-Y biliary-enteric anastomosis

  • Divyanshoo Rai Kohli;Bashar A. Aqel;Nicole L. Segaran;M. Edwyn Harrison;Norio Fukami;Douglas O. Faigel;Adyr Moss;Amit Mathur;Winston Hewitt;Nitin Katariya;Rahul Pannala
    • Annals of Hepato-Biliary-Pancreatic Surgery
    • /
    • v.27 no.1
    • /
    • pp.49-55
    • /
    • 2023
  • Backgrounds/Aims: Data regarding outcomes of endoscopic retrograde cholangiography (ERC) in liver transplant (LT) recipients with biliary-enteric (BE) anastomosis are limited. We report outcomes of ERC and percutaneous transhepatic biliary drainage (PTBD) as first-line therapies in LT recipients with BE anastomosis. Methods: All LT recipients with Roux-BE anastomosis from 2001 to 2020 were divided into ERC and PTBD subgroups. Technical success was defined as the ability to cannulate the bile duct. Clinical success was defined as the ability to perform cholangiography and therapeutic interventions. Results: A total of 36 LT recipients (25 males, age 53.5 ± 13 years) with Roux-BE anastomosis who underwent biliary intervention were identified. The most common indications for a BE anastomosis were primary sclerosing cholangitis (n = 14) and duct size mismatch (n = 10). Among the 29 patients who initially underwent ERC, technical success and clinical success were achieved in 24 (82.8%) and 22 (75.9%) patients, respectively. The initial endoscope used for the ERC was a single balloon enteroscope in 16 patients, a double balloon enteroscope in 7 patients, a pediatric colonoscope in 5 patients, and a conventional reusable duodenoscope in 1 patient. Among the 7 patients who underwent PTBD as the initial therapy, six (85.7%) achieved technical and clinical success (p = 0.57). Conclusions: In LT patients with Roux-BE anastomosis requiring biliary intervention, ERC with a balloon-assisted enteroscope is safe with a success rate comparable to PTBD. Both ERC and PTBD can be considered as first-line therapies for LT recipients with a BE anastomosis.